In the context of rising global health challenges, the mechanistic investigation and
treatment of complex diseases, including cancer, liver diseases, has emerged as a
vital focus in scientific research. A thorough understanding of basic biological
processes is crucial for the development of tools that aid in diagnosing, monitoring,
and treating human diseases. This doctoral thesis investigates the molecular
mechanisms underlying complex human diseases, with an emphasis on discovering
novel therapeutic targets and compounds though systems biology approaches. By
leveraging large-scale transcriptomic data, this work aims to uncover novel insights
into disease biology that can drive drug repositioning and precision medicine. The
thesis integrates various computational strategies and biological frameworks to
connect gene expression patterns with disease progression and therapeutic
opportunities, focusing primarily on cancer and metabolic disorders.
The studies compiled in this thesis contribute to the understanding of human disease
biology through the systematic analysis of gene expression profiles and the
application of network-based methodologies. Paper I introduces the Human
Pathology Atlas, providing an in-depth analysis of gene expression prognostic
features across different cancer types, which improves our understanding of
relationships between gene expression and disease outcomes. Paper II and Paper
III employ gene co-expression network analysis combined with drug repositioning
strategies, identifying promising therapeutic candidates for hepatocellular
carcinoma and pancreatic ductal adenocarcinoma, respectively. These studies
illustrate how network-based approaches can locate key molecular targets and
potential repurposable drugs for various cancer types.
In Paper IV, we apply a network-based approach to investigate the dysregulated
transcriptional regulation in non-alcoholic fatty liver disease (NAFLD). This study
identifies critical genes and pathways involved in the disease progression, providing
new insights into the pathophysiology of NAFLD. Lastly, Paper V presents
comprehensive review on the emerging role of PKLR in liver diseases, highlighting
its connection to metabolic diseases. This review discusses PKLR’s potential as a
therapeutic target, providing a foundation for future studies in metabolic disease
research.
In summary, this thesis contributes to the field of systems biology by integrating
gene expression and network methodologies, offering innovative strategies for
therapeutic development and personalized medicine across complex diseases.